The ISSCR's Stem Cell-Based Clinical Trials: Practical Advice for Physicians and Ethics/Institutional Review Committees was honored today by Tech Spotlight at Harvard Kennedy School's Belfer Center. Tech Spotlight recognizes the technologists, activists, and policymakers who are thoughtfully creating and using technology in ways to protect the public good and help shape a better future.
The ISSCR created Stem Cell-Based Clinical Trials: Practical Advice for Physicians and Ethics/Institutional Review Committees to address the knowledge gap generated by rapid growth in the field.
The Society is keenly aware of the rapid advances in stem cell science and regenerative medicine and is committed to assisting physicians by sharing guidance they need to navigate this evolving field, particularly as it relates to evaluation and approval of human trials. We are thrilled to be recognized by Tech Spotlight."
Christine Mummery, President, International Society for Stem Cell Research
Developed by practicing physician-scientists and stem cell professionals on the ISSCR's Clinical Translation Committee, the guide establishes a series of questions and criteria to determine whether a particular early-phase cell-based clinical trial is based on strong and rational preclinical evidence and is reasonably expected to meet patient needs and to be safe and effective, regardless of disease area or approach.
Tech Spotlight received more than 200 submissions from 18 countries in this inaugural year. Watch the Fireside Chat with Roger Barker, University of Cambridge, UK about this resource and the video announcement.
The ISSCR thanks members Roger Barker, Melissa Carpenter, Catriona Jamieson, Stuart Forbes, Steven Goldman, Charles Murry, Jun Takahashi, and Gordon Weir for their innumerous contributions to developing this resource for community.
Proteasomes: Expanding roles beyond cellular waste management